Morgan Stanley analyst Craig Hettenbach upgraded Doximity (DOCS) to Equal Weight from Underweight with a price target of $53, up from $33.

In a report released today, Jailendra Singh from Truist Financial assigned a Hold rating to Doximity (DOCS – Research Report). The ...

Morgan Stanley has upgraded Doximity (DOCS) to equal weight from underweight, citing renewed momentum in its business and conservative Q4 guidance. Read more here.

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. CareDx (CDNA) is a stock that can certainly grab the attention ...

The round saw participation from Perplexity CTO Denis Yarats, Kleiner Perkins Scout Fund, Y Combinator, Snorkel AI CEO Alex ...

Fintel reports that on November 13, 2024, Canaccord Genuity downgraded their outlook for Doximity (NYSE:DOCS) from Buy to ...